Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer.
Lin CY, Ström A, Li Kong S, Kietz S, Thomsen JS, Tee JB, Vega VB, Miller LD, Smeds J, Bergh J, Gustafsson JA, Liu ET
Breast Cancer Res 2007, 9:R25
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Estrogen receptor beta: an overview and update.
Zhao C, Dahlman-Wright K, Gustafsson JA
Nucl Recept Signal 2008, 6:e003
 [PubMed Central] [PubMed] [Related articles]
2.
The genome landscape of ERalpha- and ERbeta-binding DNA regions.
Liu Y, Gao H, Marstrand TT, Ström A, Valen E, Sandelin A, Gustafsson JA, Dahlman-Wright K
Proc Natl Acad Sci U S A 2008 Feb 19, 105:2604-9
 [PubMed Central] [PubMed] [Related articles]
3.
ERbeta in breast cancer--onlooker, passive player, or active protector?
Fox EM, Davis RJ, Shupnik MA
Steroids 2008 Oct, 73:1039-51
 [PubMed Central] [PubMed] [Related articles]
4.
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells.
Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM
Nucleic Acids Res 2009 May, 37:2584-95
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.